Two Cambridge-based biotechs, Camena Bioscience and Constructive Bio, have joined a project led by Germany's Max-Planck Institute of Molecular Plant Physiology to develop synthetic chloroplast genomes ...

Constructive Bio Strengthens Management Team and Board of Directors with Key Appointments to Accelerate Synthetic Genomics to Innovate Biologic Therapies Industry veteran Dr Paul Wallace appointed as ...

Project backed by £9.1m funding from ARIA, the Advanced Research + Invention Agency, to develop synthetic chloroplast genomes Project is led by the Max-Planck Institute of Molecular Plant Physiology ...

Contructive Bio, a genome engineering start-up founded by University of Cambridge molecular biologist Jason Chin, has secured $58 million in series A financing, bringing its total raised capital to ...

Industry veteran Dr Paul Wallace appointed as Chief Business Officer bringing 25 years of international business development experience commercialising innovative platforms and therapeutics Boston, MA ...